KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogenomics (NEO) Income from Continuing Operations (2016 - 2026)

Neogenomics filings provide 17 years of Income from Continuing Operations readings, the most recent being 17106000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 34.01% to 17106000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 99208000.0, a 27.87% decrease, with the full-year FY2025 number at 108025000.0, down 37.22% from a year prior.
  • Income from Continuing Operations hit 17106000.0 in Q1 2026 for Neogenomics, down from 9881000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9881000.0 in Q4 2025 to a low of 49408000.0 in Q1 2022.
  • Median Income from Continuing Operations over the past 5 years was 24331000.0 (2023), compared with a mean of 25651470.59.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 146.53% in 2022 and later surged 49.76% in 2023.
  • Neogenomics' Income from Continuing Operations stood at 22687000.0 in 2022, then soared by 36.85% to 14326000.0 in 2023, then dropped by 6.97% to 15324000.0 in 2024, then surged by 35.52% to 9881000.0 in 2025, then crashed by 73.12% to 17106000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 17106000.0 (Q1 2026), 9881000.0 (Q4 2025), and 27129000.0 (Q3 2025) per Business Quant data.